Chromosome 3q amplification leads to up-regulation of eIF5A2 in cancers, disturbing the well-regulated translational level maintained by eIF5A1 and leading to aberrant activation of protein synthesis pathway; as the result, normal cells are transformed to more aggressive cancerous cells. Here, EIF5A2 is linked to cancer.